PMS33 COST EFFECTIVENESS OF ABATACEPT IN COMPARISON WITH OTHER BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS PATIENTS WHO HAVE FAILED TO METHOTREXATE BASED TREATMENT AT ESSALUD IN 2010

Autor: Becerra Rojas, F., Benites Chacaltana, C., Aiello, E.C., Zingoni, C., Bergman, G., Drost, P., Valencia, J.E., Sanabria Montañez, C.
Zdroj: In Value in Health 2011 14(3):A129-A129
Databáze: ScienceDirect